Disability-adjusted life years analysis: Implications for stroke research

Journal of Clinical Neurology (Korea)

Volumn 7, Issue 3, 2011, Pages 109-114

  Hong, Keun Sik ^a  

^a Inje University   (South Korea)

Author keywords

DALY; Disability adjusted life years lost; Stroke

Indexed keywords

EID: 80053457912     PISSN: 17386586     EISSN: 20055013     Source Type: Journal    
DOI: 10.3988/jcn.2011.7.3.109     Document Type: Review

References (24)

1. Murray CJL. Rethinking DALYs. In: Murray CJL, Lopez AD. The Global Burden of Disease. Vol 1 of Global Burden of Disease and Injury Series. Cambridge, MA: Harvard School of Public Health, 1996;1-98.
2. WHO. The Global Burden of Disease: 2004 Update [Accessed 2009 Feb 4]. Available from: http://www.who.int/healthinfo/global_bur-den_disease/2004_report_update/en/index.html.
3. WHO. Global Burden of Disease 2004 Update: Disability Weights for Diseases and Conditions [Accessed 2009 Feb 4]. Available from: http://www.who.int/healthinfo/global_burden_disease/GBD2004_DisabilityWeights.pdf.
4. Ezzati M, Hoorn SV, Rodgers A, Lopez AD, Mathers CD, Murray CJ; Comparative Risk Assessment Collaborating Group. Estimates of global and regional potential health gains from reducing multiple major risk factors. Lancet 2003;362:271-280.
5. Moodie ML, Carter R, Mihalopoulos C, Thrift AG, Chambers BR, Donnan GA, et al. Trial application of a Model of Resource Utilization, Costs, and Outcomes for Stroke (MORUCOS) to assist priority setting in stroke. Stroke 2004;35:1041-1046.
6. Hong KS, Saver JL. Quantifying the value of stroke disability outcomes: WHO global burden of disease project disability weights for each level of the modified Rankin Scale. Stroke 2009;40:3828-3833.
7. Hong KS, Saver JL. Years of disability-adjusted life gained as a result of thrombolytic therapy for acute ischemic stroke. Stroke 2010;41: 471-477.
8. Hong KS, Saver JL, Kang DW, Bae HJ, Yu KH, Koo J, et al. Years of optimum health lost due to complications after acute ischemic stroke: disability-adjusted life-years analysis. Stroke 2010;41:1758-1765.
9. Eriksson M, Norrving B, Terént A, Stegmayr B. Functional outcome 3 months after stroke predicts long-term survival. Cerebrovasc Dis 2008; 25:423-429.
10. Slot KB, Berge E, Dorman P, Lewis S, Dennis M, Sandercock P. Impact of functional status at six months on long term survival in patients with ischaemic stroke: prospective cohort studies. BMJ 2008;336:376-379.
11. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 1998;352:1245-1251.
12. Ogawa A, Mori E, Minematsu K, Taki W, Takahashi A, Nemoto S, et al. Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: the middle cerebral artery embolism local fibrinolytic intervention trial (MELT) Japan. Stroke 2007; 38:2633-2639.
13. Bae HJ, Yoon DS, Lee J, Kim BK, Koo JS, Kwon O, et al. In-hospital medical complications and long-term mortality after ischemic stroke. Stroke 2005;36:2441-2445.
14. Hong KS, Kang DW, Koo JS, Yu KH, Han MK, Cho YJ, et al. Impact of neurological and medical complications on 3-month outcomes in acute ischaemic stroke. Eur J Neurol 2008;15:1324-1331.
15. Sulter G, Elting JW, Langedijk M, Maurits NM, De Keyser J. Admitting acute ischemic stroke patients to a stroke care monitoring unit versus a conventional stroke unit: a randomized pilot study. Stroke 2003; 34:101-104.
16. Hinchey JA, Shephard T, Furie K, Smith D, Wang D, Tonn S, et al. Formal dysphagia screening protocols prevent pneumonia. Stroke 2005; 36:1972-1976.
17. Korea Centers for Disease Control and Prevention. Construction of National Surveillance System for Cardiovascular & Cerebrovascular Diseases. 2006.
18. Brott TG, Hobson RW 2nd, Howard G, Roubin GS, Clark WM, Brooks W, et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med 2010;363:11-23.
19. Peeters A, Mamun AA, Willekens F, Bonneux L. A cardiovascular life history. A life course analysis of the original Framingham Heart Study cohort. Eur Heart J 2002;23:458-466.
20. Hong KS, Ali LK, Selco SL, Fonarow GC, Saver JL. Weighting components of composite end points in clinical trials: an approach using disability-adjusted life-years. Stroke 2011;42:1722-1729.
21. Maddox TM, Reid KJ, Spertus JA, Mittleman M, Krumholz HM, Parashar S, et al. Angina at 1 year after myocardial infarction: prevalence and associated findings. Arch Intern Med 2008;168:1310-1316.
22. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, et al. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009;119:480-486.
23. Johnston SC, Mendis S, Mathers CD. Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling. Lancet Neurol 2009;8:345-354.
24. Hong KS, Kim J, Cho YJ, Seo SY, Hwang SI, Kim SC, et al. Burden of ischemic stroke in Korea: analysis of disability-adjusted life years lost. J Clin Neurol 2011;7:77-84.